Delvigne A, Vandromme J, Barlow P, Lejeune B, Leroy F
IVF Clinic, Saint Pierre Hospital, Free University of Brussels, Belgium.
Hum Reprod. 1991 Aug;6(7):959-62. doi: 10.1093/oxfordjournals.humrep.a137469.
Among 599 trials of in-vitro fertilization (IVF) treatment, complicated ovarian hyperstimulation (OHSS) was diagnosed in 14 cases (2.5%) on the basis of heavy abdominal discomfort and echographic findings (ascites, ovarian enlargement with cysts). Among eight hospitalized patients, four presented with a haemoconcentration and/or electrolytic disturbances. OHSS cases were compared with two control groups for a series of criteria: age, aetiology of infertility, total dose of human menopausal gonadotrophin (HMG), day of oocyte collection, oestradiol (E2) peak level, rate of E2 increase, number of oocytes, number of embryos transferred and embryonic vitality scores. Comparison with a random group of normal IVF trials showed a significant difference for the following parameters: E2 peak level and rate of increase, E2/dose of HMG, E2/day of egg collection and number of oocytes. When OHSS cases were compared to another control group consisting only of high E2 responders (peak E2 greater than 2700 pg/ml), no significant difference was found for any of the above-mentioned criteria. In view of this lack of predictive power of individual criteria, stepwise discriminant analysis was applied, showing that this method might provide a predictive mathematical function for evaluating the risk of OHSS before human chorionic gonadotrophin (HCG) administration. Such a formula, however, should be validated by a multicentric study in which a greater number of OHSS cases would be tested.
在599例体外受精(IVF)治疗试验中,根据严重的腹部不适和超声检查结果(腹水、卵巢囊肿伴增大),确诊14例(2.5%)为复杂卵巢过度刺激综合征(OHSS)。在8例住院患者中,4例出现血液浓缩和/或电解质紊乱。将OHSS病例与两个对照组在一系列标准上进行比较:年龄、不孕病因、人绝经期促性腺激素(HMG)总剂量、取卵日、雌二醇(E2)峰值水平、E2升高率、卵母细胞数量、移植胚胎数量和胚胎活力评分。与一组随机的正常IVF试验组比较,以下参数有显著差异:E2峰值水平和升高率、E2/HMG剂量、E2/取卵日及卵母细胞数量。当将OHSS病例与另一个仅由高E2反应者(E2峰值大于2700 pg/ml)组成的对照组比较时,上述任何标准均未发现显著差异。鉴于个体标准缺乏预测能力,应用逐步判别分析,结果显示该方法可能提供一种预测数学函数,用于在注射人绒毛膜促性腺激素(HCG)前评估OHSS风险。然而,这样一个公式应由多中心研究进行验证,在该研究中要对更多的OHSS病例进行测试。